Not exact matches
The use of proteasome inhibitors to treat
cancer has been greatly
limited by the ability of
cancer cells to develop resistance to these drugs.
This widespread lack of the need for telomerase is used
by evolution as a key component of our defense against
cancer, because having a
limit to the size and renewal of telomeres prevents our
cells from replicating themselves indefinitely — the crucial hallmark of
cancer.
VLX600 is a mild inhibitor of mitochondrial respiration, and we have found that dormant
cancer cells have a
limited possibility to compensate decreased mitochondrial function
by increased glycolysis.
The researchers say that the
limited success of these drugs could be partly explained
by this newly discovered role of integrins within the
cancer cell.
While previous research had shown some effectiveness of this molecule in a mouse model of ovarian
cancer, that benefit was
limited by the immunosuppressive environment within tumors, particularly the presence of regulatory T
cells (Tregs).
This two - step strategy would starve
cancer cells — which tend to require much higher amounts of energy than normal
cells —
by limiting their two major pathways for ATP production.
One hallmark of
cancer is the accelerated metabolism, high energy requirements, and increased glucose uptake
by the tumor
cells, the latter being the first and rate -
limiting step for glucose metabolism [2,3].
Muehlenbachs said further study was
limited by the patient's death and the fact that researchers have been unable to grow tapeworm
cancer cells in the lab.
The knowledge about how this
cancer form arises and develops is still
limited but new results from a research team led
by Lene Uhrbom, Uppsala University / SciLifeLab, shows that disease progress and the malignancy are affected
by the
cell type from which the tumor originates as well as the age of the patient.
Areas covered
by Cancer Cell include, but are not limited to, molecular and cellular mechanisms of cancer, mechanisms for the sensitivity and the resistance to cancer therapies, and development of better cancer ther
Cancer Cell include, but are not
limited to, molecular and cellular mechanisms of
cancer, mechanisms for the sensitivity and the resistance to cancer therapies, and development of better cancer ther
cancer, mechanisms for the sensitivity and the resistance to
cancer therapies, and development of better cancer ther
cancer therapies, and development of better
cancer ther
cancer therapies.
The restriction of cellular growth
by p53 has been reported to result in
cell cycle arrest or apoptosis [6], and targeting p53 and restoring p53 function to
limit tumor growth has been intensively researched for
cancer therapy [7].
Cancer cells have developed a number of ways to survive, including ways to escape detection and attack
by our immune system, but their ability to respond to viral infections is actually quite
limited.
The «claims» are claims for damages and loss for personal injury (
limited to chronic obstructive pulmonary disease and / or chronic bronchitis (known together as «non-malignant respiratory disease»), temporary exacerbation of asthma («TEA»), squamous
cell skin
cancer, lung
cancer or bladder
cancer) arising out of the employment of the workers named in the group register at various coke ovens owned and operated at various times
by British Steel or other companies for whom British Steel have liabilities.